Neuroendocrine cells are unique in their ability to act both as nerve cells and hormone-making cells. They're scattered ...

Cancer treatment has long been haunted by the same problem: how do you strike dangerous cells without hitting healthy ones ...

Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, according to a study published in Communications Medicine.

Researchers at Michigan Medicine report a potential new therapeutic target for gastrointestinal neuroendocrine tumors: a ...

Existing oncology therapeutics are either so specific they can target only part of a tumor, or so generalized they kill healthy tissue. A new “Tumor Activated Therapy™” in development at the small ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

Cancer cells may be exploiting a common antioxidant as fuel, revealing a potential weakness that future therapies could ...

Scientists have engineered Salmonella bacteria to self-destruct inside tumors, releasing signals that spark powerful immune hubs and shrink colon cancer in mice, opening the door to “living medicines” ...

A gene called KLF5 may be a key force behind the spread of pancreatic cancer—but not in the way scientists expected. Rather than mutating DNA, it rewires how genes are turned on and off, helping ...

Targeted liposomal nanoparticles successfully cross the blood brain barrier to treat glioblastoma and doubled survival rates ...

We are focused on targeting tumor recurrence by developing therapies that enable the immune system to build up active immunity against residual cancer cells. Active immunity is the only long-lasting ...